A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006
Clinical trial NCT01463098 · COMPLETED
Trial details
- NCT number
- NCT01463098
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-05
- Primary completion
- 2012-08-11
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.